Article metrics

Extended report
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)

 

Online download statistics by month:

Online download statistics by month: December 2016 to November 2024

AbstractFullPdf
Dec 2016493263263
Jan 2017410273204
Feb 20173619294
Mar 2017719292
Apr 2017130088
May 20172628185
Jun 201772495202
Jul 2017217218141
Aug 2017228229102
Sep 2017176176125
Oct 201720120185
Nov 201720220480
Dec 201721021266
Jan 2018421422106
Feb 201821419383
Mar 201835734290
Apr 201830730697
May 2018234236101
Jun 201818318559
Jul 201822122172
Aug 2018259259112
Sep 201821321376
Oct 201825225288
Nov 201826726775
Dec 201819419442
Jan 201920320259
Feb 201921221271
Mar 201919419491
Apr 201914514487
May 201912512578
Jun 201910910952
Jul 201914714778
Aug 2019141140100
Sep 201913613575
Oct 201912812779
Nov 201915415263
Dec 201913913975
Jan 202012412377
Feb 2020169169104
Mar 2020185186112
Apr 202014714682
May 2020225225104
Jun 202013913880
Jul 2020201198118
Aug 202015615594
Sep 202019719273
Oct 2020178178126
Nov 202018918885
Dec 202017216999
Jan 202117217089
Feb 202112512479
Mar 202115815871
Apr 2021989849
May 202110510461
Jun 2021807931
Jul 2021636049
Aug 2021868470
Sep 20211009965
Oct 202113111483
Nov 202114611691
Dec 202112210054
Jan 202211710966
Feb 202210110749
Mar 2022959845
Apr 202214413043
May 202218616360
Jun 202211211358
Jul 202211910444
Aug 202215413441
Sep 202215213043
Oct 202212812058
Nov 202212611663
Dec 2022806521
Jan 202312310938
Feb 202311810424
Mar 202315314446
Apr 2023725932
May 2023927939
Jun 2023716520
Jul 2023978951
Aug 202312311145
Sep 202312210933
Oct 202337136140
Nov 202348647830
Dec 202312112127
Jan 2024867436
Feb 202411810430
Mar 2024947462
Apr 2024978531
May 2024807239
Jun 2024999145
Jul 20241097745
Aug 20241038032
Sep 2024918542
Oct 2024968354
Nov 202412510852
Total15239160237066